Back

Cardiac resynchronisation therapy - rebuttal and discussion

19 May 2025 (12:00 - 12:15)
Organised by: Logo
Congress Presentation Part of: Controversies about implantable cardioverter-defibrillator and cardiac resynchronisation therapy Device Therapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

5 More presentations in this session

Presentation thumbnail
Implantable cardioverter-defibrillator in primary prevention should be leadless
Associate Professor A. Abdin (Homburg, DE)
Slides Video
Presentation thumbnail
Implantable cardioverter-defibrillator in primary prevention should be endovascular lead
Doctor K. Witte (Leeds, GB)
Slides Video
Presentation thumbnail
Implantable cardioverter-defibrillator in primary prevention - rebuttal and discussion
Video
Presentation thumbnail
Cardiac resynchronisation therapy via coronary sinus lead
Professor M. Abdelhamid (Cairo, EG)
Slides Video
Presentation thumbnail
Cardiac resynchronisation therapy via conduction system pacing
Doctor A. Zupan Meznar (Ljubljana, SI)
Slides Video

Access the full session

Session thumbnail
Controversies about implantable cardioverter-defibrillator and cardiac resynchronisation therapy
Video

The Event

Event poster

Heart Failure 2025

19 May 2025 12:00 CET
You may be interested in
thumbnail
Congress Session
Joining forces to achieve optimal use of cardiac rhythm management devices - take part in the interactive case-based discussion!
thumbnail
Congress Presentation
Conduction system pacing in the current treatment of HFrEF patients
thumbnail
Congress Session
Conduction system pacing or cardiac resynchronisation therapy in HFrEF with wide QRS

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources